Zacks: Peregrine Pharma – On the Verge of Releasing First Oncology Drug to Market
Peregrine Pharma (PPHM) recently announced that the US. Food and Drug Administration (FDA) has approved on the design for their Phase III registration trial for its oncology drug, Bavituximab.